The adjuvant role of thyroxine in the treatment of chronic hepatitis C infection. (Record no. 20944482)

MARC details
000 -LEADER
fixed length control field 01269 a2200349 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516043159.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201210s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1460-2393
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1093/qjmed/hcr094
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Tran, H A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20121011
245 00 - TITLE STATEMENT
Title The adjuvant role of thyroxine in the treatment of chronic hepatitis C infection.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. QJM : monthly journal of the Association of Physicians
Date of publication, distribution, etc. Jul 2012
300 ## - PHYSICAL DESCRIPTION
Extent 683-7 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiviral Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatitis C, Chronic
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferon-alpha
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ribavirin
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thyroid Diseases
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thyroxine
General subdivision therapeutic use
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ianna, E A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jones, T L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Reeves, G E M
773 0# - HOST ITEM ENTRY
Title QJM : monthly journal of the Association of Physicians
Related parts vol. 105
-- no. 7
-- p. 683-7
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1093/qjmed/hcr094">https://doi.org/10.1093/qjmed/hcr094</a>
Public note Available from publisher's website

No items available.